JCR Pharmaceuticals Co., Ltd. (TYO: 4552)
Japan
· Delayed Price · Currency is JPY 585.00
-7.00 (-1.18%)
Jan 9, 2025, 3:45 PM JST
JCR Pharmaceuticals Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 8, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 71,268 | 107,204 | 176,306 | 279,312 | 443,148 | 290,393 | Upgrade
|
| Market Cap Growth | -56.06% | -39.19% | -36.88% | -36.97% | 52.60% | 44.66% | Upgrade
|
| Enterprise Value | 81,754 | 112,497 | 181,176 | 266,306 | 440,087 | 290,967 | Upgrade
|
| Last Close Price | 585.00 | 846.59 | 1366.65 | 2158.42 | 3397.84 | 2224.04 | Upgrade
|
| PE Ratio | - | 19.47 | 46.74 | 19.25 | 64.30 | 108.44 | Upgrade
|
| Forward PE | 16.64 | 15.46 | 25.97 | 25.23 | 65.14 | 63.78 | Upgrade
|
| PS Ratio | 2.07 | 2.50 | 5.13 | 5.47 | 14.73 | 11.72 | Upgrade
|
| PB Ratio | 1.29 | 1.90 | 3.36 | 5.47 | 11.49 | 8.91 | Upgrade
|
| P/TBV Ratio | 1.53 | 2.03 | 3.63 | 5.83 | 12.61 | 9.04 | Upgrade
|
| P/FCF Ratio | 71.13 | 13.77 | - | - | 79.69 | 3262.84 | Upgrade
|
| P/OCF Ratio | 17.52 | 11.51 | - | 30.07 | 42.85 | 58.94 | Upgrade
|
| PEG Ratio | 1.77 | 1.77 | 1.77 | 1.77 | 1.77 | 1.77 | Upgrade
|
| EV/Sales Ratio | 2.32 | 2.62 | 5.28 | 5.21 | 14.63 | 11.74 | Upgrade
|
| EV/EBITDA Ratio | 34.86 | 10.49 | 25.98 | 12.17 | 43.23 | 62.19 | Upgrade
|
| EV/EBIT Ratio | - | 14.94 | 36.40 | 13.36 | 53.09 | 89.67 | Upgrade
|
| EV/FCF Ratio | 81.59 | 14.45 | - | - | 79.14 | 3269.29 | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.41 | 0.44 | 0.35 | 0.47 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 8.54 | 2.17 | 3.27 | 0.83 | 1.78 | 1.87 | Upgrade
|
| Debt / FCF Ratio | 28.36 | 2.99 | - | - | 3.25 | 98.39 | Upgrade
|
| Asset Turnover | 0.34 | 0.43 | 0.36 | 0.60 | 0.49 | 0.55 | Upgrade
|
| Inventory Turnover | 0.48 | 0.59 | 0.54 | 0.74 | 0.70 | 0.88 | Upgrade
|
| Quick Ratio | 0.90 | 1.12 | 0.68 | 1.11 | 1.19 | 1.84 | Upgrade
|
| Current Ratio | 1.65 | 1.91 | 1.34 | 1.48 | 1.67 | 2.72 | Upgrade
|
| Return on Equity (ROE) | -0.71% | 10.17% | 7.32% | 32.39% | 19.37% | 8.44% | Upgrade
|
| Return on Assets (ROA) | -0.12% | 4.78% | 3.24% | 14.58% | 8.52% | 4.49% | Upgrade
|
| Return on Capital (ROIC) | -0.15% | 6.07% | 4.31% | 19.80% | 10.57% | 5.20% | Upgrade
|
| Earnings Yield | -0.60% | 5.14% | 2.14% | 5.19% | 1.56% | 0.92% | Upgrade
|
| FCF Yield | 1.41% | 7.26% | -7.46% | -0.73% | 1.25% | 0.03% | Upgrade
|
| Dividend Yield | 3.38% | 2.36% | 1.46% | 0.93% | 0.34% | 0.36% | Upgrade
|
| Payout Ratio | 0.00% | 45.40% | 72.61% | 14.95% | 15.71% | 36.93% | Upgrade
|
| Buyback Yield / Dilution | 0.32% | -0.45% | -0.51% | -0.06% | -0.07% | -0.14% | Upgrade
|
| Total Shareholder Return | 3.70% | 1.91% | 0.96% | 0.86% | 0.27% | 0.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.